Skip to main content

Table 6 Relationship between health resource utilization and incontinence status a

From: Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity

Variables

Incontinence statusb

Continent

Incontinent

(n = 78)

(n = 235)

Proportion of patients having OAB-related hospitalization experience during the past 12 months‡

USA

1 (5.0%)

3 (4.6%)

Europe

9 (15.8%)

31 (18.2%)

Total

10 (12.8%)

34 (14.5%)

Proportion of patients that ever had OAB-related surgery‡

USA

2 (9.5%)

10 (15.9%)

Europe

6 (10.5%)

11 (6.5%)

Total

8 (10.3%)

21 (9.1%)

Proportion of patients that had switched anticholinergics used for OAB due to efficacy/side effects‡

USA

6 (28.6%)

15 (23.1%)

Europe

18 (31.6%)

46 (27.1%)

Total

24 (30.8%)

61 (26.0%)

Proportion of patients currently using pads (at the time of completing the survey) ‡

USA**

4 (19.0%)

40 (61.5%)

Europe***

6 (10.5%)

127 (75.6%)

Total***

10 (12.8%)

167 (71.7%)

Number of OAB-related physician visits over the past 3 months‡‡

USA

1.3 (1.2)

1.5 (1.3)

Europe

2.2 (2.4)

2.5 (2.3)

Total

2.0 (2.1)

2.2 (2.0)

Number of pads used per week‡‡

USA

4.5 (12.2)

10.8 (14.4)

Europe***

0.8 (2.4)

9.3 (9.0)

Total***

1.8 (6.7)

9.7 (10.8)

  1. aBivariate analyses comparing burden of illness between incontinent versus non-incontinent group.
  2. b11 out of 324 NDO patients had unknown incontinent status.
  3. *p < 0.05 **p < 0.01 ***p < 0.001 in chi-square test, Fisher’s exact test, t-test, or Wilcoxon rank-sum test as appropriate.
  4. ‡Data are presented as number (percentage).
  5. ‡‡Data are presented as mean (standard deviation).